Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRheumatoid arthritis is added as a primary condition on the page, and a related topics section now includes MedlinePlus Genetics. These changes provide direct context for the study and link to additional resource information.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision label to v3.3.2; older PubMed explanatory text and topic list were removed.SummaryDifference0.1%

- Check28 days agoChange DetectedNotice about lapse in government funding was removed from the page. The study details, eligibility criteria, and locations list remain the same.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the Study Details page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page no longer lists Rheumatoid arthritis and the related MedlinePlus Genetics topic in the topics/links sections. This reduces the presence of RA context and related resources on the study page, potentially affecting findability for RA information.SummaryDifference0.2%

- Check70 days agoChange Detected- Added a government operating status notice and reference to NIH Clinical Center operations, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0; removed old v3.1.0.SummaryDifference1%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.